Cargando…
In Vitro Biotransformation and Anti-Inflammatory Activity of Constituents and Metabolites of Filipendula ulmaria
(1) Background: Filipendula ulmaria (L.) Maxim. (Rosaceae) (meadowsweet) is widely used in phytotherapy against inflammatory diseases. However, its active constituents are not exactly known. Moreover, it contains many constituents, such as flavonoid glycosides, which are not absorbed, but metabolize...
Autores principales: | Van der Auwera, Anastasia, Peeters, Laura, Foubert, Kenn, Piazza, Stefano, Vanden Berghe, Wim, Hermans, Nina, Pieters, Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146082/ https://www.ncbi.nlm.nih.gov/pubmed/37111776 http://dx.doi.org/10.3390/pharmaceutics15041291 |
Ejemplares similares
-
Study of the Antioxidant Properties of Filipendula ulmaria and Alnus glutinosa
por: Sukhikh, Stanislav, et al.
Publicado: (2022) -
Compound Characterization and Metabolic Profile Elucidation after In Vitro Gastrointestinal and Hepatic Biotransformation of an Herniaria hirsuta Extract Using Unbiased Dynamic Metabolomic Data Analysis
por: Peeters, Laura, et al.
Publicado: (2020) -
Variations in Yield, Essential Oil, and Salicylates of Filipendula ulmaria Inflorescences at Different Blooming Stages
por: Ložienė, Kristina, et al.
Publicado: (2023) -
Xanthine Oxidase Inhibitors from Filipendula ulmaria (L.) Maxim. and Their Efficient Detections by HPTLC and HPLC Analyses
por: Gainche, Maël, et al.
Publicado: (2021) -
The Antioxidant Supplementation with Filipendula ulmaria Extract Attenuates the Systemic Adverse Effects of Nanosized Calcium Phosphates in Rats
por: Scepanovic, Radomir, et al.
Publicado: (2021)